Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $75,488 | 44 | 25.4% |
| Honoraria | $70,000 | 31 | 23.6% |
| Consulting Fee | $53,794 | 24 | 18.1% |
| Food and Beverage | $50,754 | 2,657 | 17.1% |
| Travel and Lodging | $45,609 | 125 | 15.3% |
| Education | $1,565 | 30 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sirtex Medical Inc | $158,972 | 213 | $0 (2024) |
| Genentech USA, Inc. | $23,850 | 175 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $18,199 | 93 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $12,241 | 41 | $0 (2024) |
| Lilly USA, LLC | $11,849 | 45 | $0 (2024) |
| Eisai Inc. | $8,034 | 66 | $0 (2024) |
| SEAGEN INC. | $7,783 | 38 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $7,665 | 153 | $0 (2024) |
| Celgene Corporation | $4,663 | 152 | $0 (2024) |
| PFIZER CHILE S.A. | $4,311 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20,146 | 379 | Sirtex Medical Inc ($5,200) |
| 2023 | $31,039 | 324 | Sirtex Medical Inc ($10,500) |
| 2022 | $35,125 | 304 | Sirtex Medical Inc ($21,191) |
| 2021 | $28,912 | 302 | Sirtex Medical Inc ($15,294) |
| 2020 | $14,378 | 259 | Sirtex Medical Inc ($6,000) |
| 2019 | $34,968 | 459 | Sirtex Medical Inc ($24,994) |
| 2018 | $84,115 | 498 | Sirtex Medical Inc ($54,124) |
| 2017 | $48,526 | 386 | Sirtex Medical Inc ($21,669) |
All Payment Transactions
2,911 individual payment records from CMS Open Payments — Page 1 of 117
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/22/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $32.10 | General |
| Category: Oncology | ||||||
| 12/20/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Oncology | ||||||
| 12/19/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $25.83 | General |
| Category: Oncology | ||||||
| 12/19/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: Oncology | ||||||
| 12/18/2024 | Celgene Corporation | ONUREG (Drug) | Food and Beverage | Cash or cash equivalent | $34.91 | General |
| Category: Oncology | ||||||
| 12/17/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: Oncology | ||||||
| 12/17/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $18.21 | General |
| Category: Hematology/Oncology | ||||||
| 12/16/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $29.45 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $16.25 | General |
| Category: Hematology | ||||||
| 12/11/2024 | PFIZER INC. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Oncology | ||||||
| 12/09/2024 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $27.94 | General |
| 12/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Oncology | ||||||
| 12/04/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: DESMOID TUMORS | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: Oncology | ||||||
| 12/03/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $2.37 | General |
| Category: NONE | ||||||
| 12/02/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $31.62 | General |
| Category: ONCOLOGY | ||||||
| 12/01/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug), TGCT | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: ONCOLOGY | ||||||
| 11/27/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $23.04 | General |
| 11/26/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $28.50 | General |
| Category: Hematology | ||||||
| 11/26/2024 | Astellas Pharma US Inc | Xospata (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Oncology | ||||||
| 11/26/2024 | GENZYME CORPORATION | ENJAYMO (Biological) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Hematology | ||||||
| 11/25/2024 | BeiGene USA, Inc. | TEVIMBRA (Drug) | Consulting Fee | Cash or cash equivalent | $1,375.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 625 | 1,502 | $289,230 | $88,281 |
| 2022 | 4 | 575 | 1,543 | $283,195 | $88,310 |
| 2021 | 5 | 755 | 1,915 | $357,497 | $111,841 |
| 2020 | 6 | 863 | 2,139 | $418,558 | $107,066 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 199 | 609 | $100,485 | $31,024 | 30.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 186 | 483 | $79,695 | $24,247 | 30.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 63 | 135 | $34,020 | $10,935 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 64 | 126 | $31,752 | $10,501 | 33.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 47 | 83 | $18,924 | $5,419 | 28.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 28 | 28 | $12,124 | $3,135 | 25.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $6,062 | $1,524 | 25.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 12 | 12 | $3,084 | $757.07 | 24.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $3,084 | $740.20 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 205 | 649 | $107,085 | $34,597 | 32.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 199 | 594 | $98,010 | $30,578 | 31.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 53 | 96 | $24,192 | $7,952 | 32.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 45 | 107 | $24,396 | $6,492 | 26.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 69 | $17,388 | $5,556 | 32.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 15 | 15 | $6,495 | $1,680 | 25.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $5,629 | $1,456 | 25.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 236 | 802 | $132,330 | $42,979 | 32.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 257 | 685 | $113,025 | $36,066 | 31.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 55 | 149 | $33,972 | $9,146 | 26.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 66 | 95 | $23,940 | $7,682 | 32.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 47 | 90 | $22,680 | $7,640 | 33.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 25 | 25 | $10,825 | $2,800 | 25.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 31 | 31 | $7,967 | $2,147 | 26.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 17 | 17 | $7,361 | $1,950 | 26.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 21 | 21 | $5,397 | $1,430 | 26.5% |
About Dr. Mike Cusnir, M.D
Dr. Mike Cusnir, M.D is a Specialist healthcare provider based in Miami Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1962490631.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mike Cusnir, M.D has received a total of $297,209 in payments from pharmaceutical and medical device companies, with $20,146 received in 2024. These payments were reported across 2,911 transactions from 102 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($75,488).
As a Medicare-enrolled provider, Cusnir has provided services to 2,818 Medicare beneficiaries, totaling 7,099 services with total Medicare billing of $395,498. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Hematology & Oncology
- Location Miami Beach, FL
- Active Since 10/07/2005
- Last Updated 07/19/2014
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1962490631
Products in Payments
- SIR-Spheres Microspheres (Device) $158,972
- Avastin (Biological) $21,675
- Stivarga (Drug) $17,708
- Onivyde (Drug) $11,004
- Lenvima (Drug) $7,842
- TUKYSA (Drug) $7,310
- BRAFTOVI (Drug) $5,356
- CYRAMZA (Drug) $3,787
- CALQUENCE (Drug) $3,144
- IMFINZI (Biological) $2,405
- Rituxan (Drug) $1,800
- KEYTRUDA (Biological) $1,620
- LONSURF (Drug) $1,545
- XTANDI (Drug) $1,526
- TEVIMBRA (Drug) $1,394
- REBLOZYL (Biological) $1,206
- IMBRUVICA (Drug) $1,068
- BRUKINSA (Drug) $1,064
- OPDIVO (Biological) $1,017
- ERLEADA (Drug) $994.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Miami Beach
Dr. Ettore Vulcano, M.d, M.D
Specialist — Payments: $236,418
Dr. Martin Zaiac, M.d, M.D
Specialist — Payments: $47,479
Juan Rivera, Md, MD
Specialist — Payments: $36,966
Dr. Arnold Blaustein, M.d, M.D
Specialist — Payments: $34,776
Dr. Michael Schwartz, M.d, M.D
Specialist — Payments: $33,081
Dr. Roy Williams, Md, MD
Specialist — Payments: $27,690